Monthly Cost Breakdown: Wegovy vs Mounjaro Comparison
Is Mounjaro or Wegovy Better for UK Monthly Budgeting?
When comparing Mounjaro versus Wegovy for monthly costs, understanding the complete financial commitment helps inform your decision. Wegovy follows a structured 16-week dose escalation starting at £79.99 monthly, progressing through £94.99, £99.99, £139.99, and reaching maintenance at £209.99 monthly for the 2.4mg dose. Mounjaro typically costs between £150-250 monthly depending on dose and supplier, making Wegovy potentially more accessible during initial treatment phases.
The question of whether Mounjaro or Wegovy is better financially depends on your treatment timeline and insurance considerations. Wegovy's graduated pricing structure allows patients to assess tolerance and effectiveness at lower monthly investments before committing to higher maintenance costs. Both prescription-only medicines require ongoing monthly expenses, but Wegovy's transparent pricing through our GPhC-registered pharmacy (#9012878) provides predictable budgeting throughout your weight management journey.
Wegovy Pricing Structure and Value Comparison
EverydayMeds offers comprehensive Wegovy pricing with new customer savings through code FIRST40 and returning customer benefits via DOSE25. The complete monthly progression includes: starter dose 0.25mg at £79.99, 0.5mg at £94.99, 1mg at £99.99, escalation dose 1.7mg at £139.99, and maintenance 2.4mg at £209.99. Bundle options provide convenience for patients planning ahead, with our Intro Duo covering first two months for £169.99.
Annual maintenance cost estimates help determine if Mounjaro or Wegovy is better for long-term affordability. At maintenance dose, Wegovy costs approximately £2,520 annually (£209.99 × 12 months), providing predictable budgeting for ongoing treatment. Our Ultimate Stability Trio offers three months of maintenance supply for £649.99, ensuring uninterrupted treatment while managing monthly cash flow effectively.
Clinical Evidence: Is Mounjaro or Wegovy Better Supported?
STEP trials demonstrate Wegovy's clinical effectiveness, with patients achieving approximately 15% average weight loss at 68 weeks alongside diet and exercise modifications (Wilding et al., NEJM, 2021). The STEP 5 trial showed sustained weight management benefits at two years, supporting long-term treatment value. Mounjaro's SURMOUNT trials show similar efficacy patterns, though direct head-to-head comparisons aren't available due to different trial designs and patient populations.
When considering whether Mounjaro or Wegovy is better clinically, both treatments require medical supervision and work through appetite regulation mechanisms. Wegovy's extensive STEP programme provides robust safety and efficacy data across diverse patient groups, including those with type 2 diabetes and cardiovascular risk factors. The SELECT cardiovascular outcomes trial further supports Wegovy's clinical value with 20% reduction in major cardiovascular events.
How Wegovy Works for Weight Management
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural hormones regulating appetite and blood sugar levels. The medication works by slowing gastric emptying, promoting feelings of fullness after smaller meals, and may reduce food cravings through effects on brain appetite centres. Unlike Mounjaro's dual GIP/GLP-1 mechanism, Wegovy specifically targets GLP-1 receptors with established clinical experience. The once-weekly injection schedule provides consistent medication levels throughout the week, supporting sustained appetite management. Patients typically notice reduced hunger and improved portion control within the first few weeks of treatment initiation.
Streamlined Ordering Process for UK Patients
EverydayMeds provides efficient access to both Wegovy and Mounjaro through our regulated online platform. The process begins with a comprehensive 3-minute clinical assessment covering medical history, current medications, and weight management goals. Our UK-registered prescribers review applications within standard 3 working days, with express 24-hour review available for urgent cases. Once approved, medications ship via next-day delivery using temperature-controlled cold-chain logistics to maintain product integrity. Our GPhC registration (#9012878) ensures full regulatory compliance and patient safety throughout the prescribing and dispensing process.
Storage and Practical Considerations
Wegovy offers significant practical advantages when determining if Mounjaro or Wegovy is better for lifestyle flexibility. The FlexTouch pre-filled pen remains stable for 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This extended stability supports travel, work schedules, and daily convenience without compromising medication effectiveness. Before first use, Wegovy requires standard refrigeration at 2-8°C, similar to other injectable medications. The dose escalation schedule prevents patients from skipping ahead, ensuring tolerance development and minimising side effects during treatment initiation.
Long-term Investment Analysis: Mounjaro vs Wegovy Better Value
Evaluating whether Mounjaro or Wegovy is better requires considering total cost of ownership beyond monthly medication prices. Wegovy's established NHS pathway through NICE TA875 may provide future coverage options for eligible patients under specialist care. The medication's proven cardiovascular benefits could offset long-term healthcare costs for patients with relevant risk factors. Wegovy's 6-week room temperature stability reduces waste from temperature excursions, protecting your monthly investment.
When determining if Mounjaro or Wegovy is better financially long-term, consider treatment duration and effectiveness sustainability. STEP trial data shows weight regain typically occurs if treatment discontinues, emphasising the importance of sustainable monthly costs for continued success. Our DOSE25 returning customer discount ensures ongoing affordability once you've established effective treatment response with Wegovy.
Making Your Decision: Expert Support Available
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment aligns with your medical profile and budget constraints. Our clinical team considers factors including medical history, current medications, lifestyle requirements, and cost considerations when recommending treatment options. New patients can start their assessment today using discount code FIRST40, while existing customers benefit from DOSE25 for continued savings. The decision between treatments should prioritise medical appropriateness alongside financial sustainability for successful long-term weight management. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment with transparent pricing and expert medical support throughout your treatment journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
